Alex Goldberg

Geron Corporation (NASDAQ:GERN) and VimpelCom Ltd. (NASDAQ:VIP) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/24/2013 -- -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Geron Corporation (NASDAQ:GERN) and VimpelCom Ltd. (NASDAQ:VIP).

Geron Corporation (NASDAQ:GERN) a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies closed up in its previous session (+7.55%) on 4,952,999 shares traded. Geron Corporation (NASDAQ:GERN) is currently up (+438.78%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Geron Corporation (NASDAQ:GERN)

VimpelCom Ltd. (NASDAQ:VIP) a company that is a telecommunications service operator, provides voice and data services through a range of traditional and broadband mobile and fixed technologies closed up in its previous session (+2.68%) on 1,773,464 shares traded as Vimpelcom eyes sale, merger, refinancing for Italy's Wind-FT. VimpelCom Ltd. (NASDAQ:VIP) is currently up (+34.1%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about VimpelCom Ltd. (NASDAQ:VIP)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com